- Article metrics
- Last updated: Thu, 2 Apr 2026 18:42:12 Z
Complex-specific inhibitors for interrogating ATAC histone acetyltransferase complex
Access & Citations
-
- 3365
- Article Accesses
-
- 1
- Citation
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 19 tweeters
- 1 blogs
- 1 Facebook pages
- 10 news outlets
- 5 Mendeley
This article is in the 98th percentile (ranked 3,309th) of the 253,659 tracked articles of a similar age in all journals and the 89th percentile (ranked 4th) of the 39 tracked articles of a similar age in Nature Chemical Biology
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. The donut visual summarises attention from different sources; a breakdown is shown in the legend. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
Targeted Inhibitors Reveal Insights into ATAC Complex
Bioengineer.org -
HKU Chemists Develop First-in-Class Inhibitor Targeting a Key Epigenetic Regulator - All News - Media - HKU
The University of Hong Kong Press Releases -
港大化學系李祥教授團隊首創ATAC抑制劑 精準抗非小細胞肺癌
bastillepost -
Epigenetic Drug Switches Off Tumor-Driving Genes in Lung Cancer
Technology Networks -
HMN 2026: How to develop first-in-class inhibitor targeting a key epigenetic regulator
Health Medicine Network
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.